Antiviral Peptides Targeting the West Nile Virus Envelope Protein
about
Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteinsFlavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoesAntibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E ProteinWest Nile Virus: biology, transmission, and human infectionIdentification of Novel Small-Molecule Inhibitors of West Nile Virus InfectionClosing the door on flaviviruses: Entry as a target for antiviral drug designMolecular mechanisms of antibody-mediated neutralisation of flavivirus infectionIL-10 Signaling Blockade Controls Murine West Nile Virus InfectionProgress on the development of therapeutics against West Nile virusStructural optimization and de novo design of dengue virus entry inhibitory peptidesInhibition of influenza A virus infection in vitro by peptides designed in silicoAnalysis and prediction of highly effective antiviral peptides based on random forestsMarine peptides and their anti-infective activitiesFlaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.A C-type lectin collaborates with a CD45 phosphatase homolog to facilitate West Nile virus infection of mosquitoes.Characterization of HCV genotype 5a envelope proteins: implications for vaccine development and therapeutic entry target.Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention.A neuron-specific antiviral mechanism prevents lethal flaviviral infection of mosquitoes.Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.Screening Analogs of β-OG Pocket Binder as Fusion Inhibitor of Dengue Virus 2.Identification of Peptide Inhibitors of Enveloped Viruses Using Support Vector Machine.Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Infectivity inhibition by overlapping synthetic peptides derived from the gH/gL heterodimer of herpes simplex virus type 1.A tripeptide (NSK) inhibits Japanese encephalitis virus infection in vitro and in vivo.Strategies for the treatment of dengue virus infections: a narrative account.Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.Prediction of antiviral peptides derived from viral fusion proteins potentially active against herpes simplex and influenza A virusesAVPpred: collection and prediction of highly effective antiviral peptides.Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2.Peptides as Therapeutic Agents for Dengue Virus.West nile virus neuroinvasive disease.
P2860
Q22570477-28DB60DA-D026-4A32-AD82-329E18D9ADD7Q24705181-DC323F2B-B2C4-4F2C-89DB-A9CE55068DD7Q26700124-7AF3A557-DDD2-4D74-95CF-C3D3512FEF14Q26865618-0BE5D7D3-A334-47D3-B378-1A5DE98B3C1EQ27484983-E03E02C1-1334-47D3-94F0-583881271F11Q27487953-02143A03-7F95-437E-9232-5DACBD4B1BE4Q27488337-9E5261CA-695F-4E19-BB06-B7005F126BDEQ27489722-16F87C74-F4AE-4237-8C0C-CF431BDE9E65Q27489893-B47BBC74-7172-4502-A41C-B75DB3F74940Q28474595-51BC1CD7-8033-4F44-A354-721E71706ECDQ28534343-EB3952B3-93DA-4A9F-B1F4-56ACFD60F650Q28535105-E52F70E7-A0EA-4982-B4A1-CF6572530984Q28651520-489C14DD-A07B-4082-9735-463B9D13B3A1Q30857727-DE915CD7-18AC-47CC-AEB3-2E55CD9A529CQ34195900-C0A7D766-B80B-4227-9111-5DBB2EF79DF1Q34864567-096AE00A-57B7-43BB-8008-8796AFBFE172Q35097106-CD29F3CA-C67B-44D4-A40C-69B7E5DFEA64Q35542492-657FF487-2B7F-4E26-B690-23862CB6A8B7Q35739141-AA00209E-5B60-49BA-848F-B2D3242C198CQ35855216-CB927F4C-4A89-4162-A3D8-E30890D44038Q35860797-A4D5C505-ED78-4347-B744-E8455BE8EB2EQ38260862-2660172E-0C44-4740-A5A1-33C74DE38933Q38866173-9F6229EC-4E1A-4946-BD72-2199F6C25391Q38962811-8B971714-226C-47CD-8FDD-78B0018D1E81Q39051535-70B5E687-6E1D-47D5-8830-223A9550D6B0Q39769368-E25C1141-A4A7-4E47-91E2-4225A634356AQ40180290-07AB0F4A-6943-41FC-8004-F611111243F2Q41493353-DE7727BB-7644-4FAF-B226-94E18FA3BAC2Q42232907-D7A750E9-BD9E-42D9-96D3-2E9A215EDF9FQ42730622-2E11E75D-6884-4C29-8CCC-8C3B278B91F5Q45323856-ECA89E3D-79A8-4B2D-85F6-E22F60633BE0Q51163679-84790548-5675-4082-8992-B3FF51E2F984
P2860
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
@ast
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
@en
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
@nl
type
label
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
@ast
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
@en
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
@nl
prefLabel
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
@ast
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
@en
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
@nl
P2093
P2860
P3181
P356
P1433
P1476
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
@en
P2093
Deepti Pradhan
Fengwei Bai
Joanna K Krueger
John F Anderson
Jonathan Cox
Raymond A Koski
Richard A Flavell
Terrence Town
P2860
P304
P3181
P356
10.1128/JVI.01840-06
P577
2007-02-01T00:00:00Z